For research use only. Not for therapeutic Use.
TP-1287（Cat No.:I037425）is an investigational antibiotic compound under development for the treatment of multidrug-resistant bacterial infections, particularly those caused by Gram-positive pathogens like methicillin-resistant Staphylococcus aureus (MRSA). It is designed to inhibit bacterial cell wall synthesis, disrupting the bacteria’s ability to replicate and survive. TP-1287 has demonstrated potent activity against resistant strains in preclinical studies, showing promise as an effective treatment option where conventional antibiotics have failed. Ongoing clinical trials are focused on evaluating its safety, efficacy, and potential as a next-generation therapy for serious bacterial infections.
| CAS Number | 2044686-42-0 |
| Synonyms | [2-(2-chlorophenyl)-5-hydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4-oxochromen-7-yl] dihydrogen phosphate |
| Molecular Formula | C21H21ClNO8P |
| Purity | ≥95% |
| IUPAC Name | [2-(2-chlorophenyl)-5-hydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4-oxochromen-7-yl] dihydrogen phosphate |
| InChI | InChI=1S/C21H21ClNO8P/c1-23-7-6-12(16(26)10-23)19-18(31-32(27,28)29)9-15(25)20-14(24)8-17(30-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,16,25-26H,6-7,10H2,1H3,(H2,27,28,29)/t12-,16+/m0/s1 |
| InChIKey | YRNFLVUMZIRYKY-BLLLJJGKSA-N |
| SMILES | CN1CC[C@@H]([C@@H](C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)OP(=O)(O)O |
